A detailed history of Hrt Financial LP transactions in Merus N.V. stock. As of the latest transaction made, Hrt Financial LP holds 29,283 shares of MRUS stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,283
Holding current value
$1.24 Million
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$47.19 - $58.84 $1.38 Million - $1.72 Million
29,283 New
29,283 $1.46 Million
Q1 2024

May 13, 2024

SELL
$28.03 - $51.82 $711,597 - $1.32 Million
-25,387 Reduced 67.21%
12,386 $557,000
Q4 2023

Feb 09, 2024

BUY
$20.06 - $28.66 $225,975 - $322,854
11,265 Added 42.5%
37,773 $1.04 Million
Q3 2023

Nov 13, 2023

BUY
$20.13 - $27.29 $533,606 - $723,403
26,508 New
26,508 $625,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.95B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.